Zeria Pharmaceutical Co Ltd
TSE:4559
Zeria Pharmaceutical Co Ltd
TSE:4559
Price:
2 009 JPY
0.45%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Zeria Pharmaceutical Co Ltd
Zeria Pharmaceutical Co Ltd
| Current Assets | 57.8B |
| Cash & Short-Term Investments | 20.3B |
| Receivables | 21.1B |
| Other Current Assets | 16.4B |
| Non-Current Assets | 92.7B |
| Long-Term Investments | 9.1B |
| PP&E | 26.5B |
| Intangibles | 43.1B |
| Other Non-Current Assets | 13.9B |
| Current Liabilities | 54.5B |
| Accounts Payable | 3.3B |
| Accrued Liabilities | 1.6B |
| Other Current Liabilities | 49.7B |
| Non-Current Liabilities | 16.4B |
| Long-Term Debt | 7.9B |
| Other Non-Current Liabilities | 8.4B |
Balance Sheet
Zeria Pharmaceutical Co Ltd
Zeria Pharmaceutical Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18 012
|
12 343
|
9 251
|
10 167
|
8 045
|
9 005
|
9 794
|
11 704
|
16 219
|
20 324
|
|
| Cash Equivalents |
18 012
|
12 343
|
9 251
|
10 167
|
8 045
|
9 005
|
9 794
|
11 704
|
16 219
|
20 324
|
|
| Short-Term Investments |
0
|
0
|
100
|
7
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Receivables |
16 223
|
14 725
|
16 587
|
15 591
|
14 911
|
13 239
|
13 497
|
16 153
|
17 420
|
21 080
|
|
| Accounts Receivables |
16 223
|
14 725
|
16 587
|
15 591
|
14 911
|
13 239
|
13 190
|
15 922
|
17 138
|
20 820
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
307
|
231
|
281
|
260
|
|
| Inventory |
8 189
|
8 013
|
8 609
|
9 376
|
10 024
|
9 563
|
11 104
|
11 951
|
12 764
|
14 490
|
|
| Other Current Assets |
3 256
|
4 614
|
4 219
|
3 365
|
5 743
|
3 213
|
2 916
|
1 856
|
1 801
|
1 915
|
|
| Total Current Assets |
45 681
|
39 695
|
38 765
|
38 506
|
38 723
|
35 020
|
37 314
|
41 664
|
48 204
|
57 809
|
|
| PP&E Net |
22 021
|
23 274
|
24 154
|
23 341
|
22 914
|
23 125
|
23 634
|
23 139
|
24 591
|
26 518
|
|
| PP&E Gross |
22 021
|
23 274
|
24 154
|
23 341
|
22 914
|
23 125
|
23 634
|
23 139
|
24 591
|
26 518
|
|
| Accumulated Depreciation |
26 541
|
28 003
|
29 060
|
29 534
|
30 302
|
31 470
|
33 203
|
34 747
|
36 420
|
38 593
|
|
| Intangible Assets |
813
|
7 276
|
6 722
|
6 897
|
7 005
|
7 309
|
7 690
|
7 836
|
8 473
|
9 380
|
|
| Goodwill |
11 531
|
28 507
|
27 163
|
25 441
|
22 794
|
22 539
|
34 380
|
33 370
|
33 457
|
33 759
|
|
| Long-Term Investments |
9 731
|
12 472
|
9 206
|
6 936
|
5 538
|
5 968
|
5 915
|
7 006
|
6 849
|
9 145
|
|
| Other Long-Term Assets |
6 490
|
7 953
|
8 347
|
14 281
|
13 460
|
10 194
|
12 927
|
11 268
|
13 459
|
13 922
|
|
| Other Assets |
11 531
|
28 507
|
27 163
|
25 441
|
22 794
|
22 539
|
34 380
|
33 370
|
33 457
|
33 759
|
|
| Total Assets |
96 268
N/A
|
119 178
+24%
|
114 358
-4%
|
115 401
+1%
|
110 434
-4%
|
104 156
-6%
|
121 860
+17%
|
124 282
+2%
|
135 035
+9%
|
150 534
+11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 384
|
2 041
|
2 273
|
2 073
|
1 763
|
1 588
|
1 694
|
2 050
|
1 996
|
3 274
|
|
| Accrued Liabilities |
1 113
|
1 244
|
1 224
|
1 208
|
1 178
|
1 222
|
1 268
|
1 531
|
1 555
|
1 585
|
|
| Short-Term Debt |
0
|
31 418
|
31 292
|
21 877
|
25 373
|
26 886
|
40 221
|
28 430
|
29 470
|
0
|
|
| Current Portion of Long-Term Debt |
11 573
|
7 620
|
1 770
|
3 050
|
2 616
|
3 050
|
4 149
|
5 643
|
5 692
|
38 284
|
|
| Other Current Liabilities |
6 842
|
5 923
|
8 620
|
7 952
|
7 909
|
8 324
|
6 465
|
6 540
|
8 445
|
11 376
|
|
| Total Current Liabilities |
21 911
|
48 246
|
45 178
|
36 160
|
38 839
|
41 070
|
53 797
|
44 193
|
47 158
|
54 518
|
|
| Long-Term Debt |
10 636
|
4 654
|
2 884
|
8 676
|
7 796
|
6 462
|
6 736
|
19 218
|
15 549
|
7 944
|
|
| Deferred Income Tax |
516
|
1 297
|
1 784
|
3 823
|
3 542
|
2 555
|
3 344
|
3 905
|
5 191
|
6 447
|
|
| Minority Interest |
0
|
332
|
153
|
164
|
162
|
168
|
167
|
198
|
231
|
206
|
|
| Other Liabilities |
635
|
914
|
1 007
|
1 045
|
910
|
1 391
|
1 830
|
1 873
|
1 456
|
1 795
|
|
| Total Liabilities |
33 698
N/A
|
55 443
+65%
|
51 006
-8%
|
49 868
-2%
|
51 248
+3%
|
51 645
+1%
|
65 875
+28%
|
69 388
+5%
|
69 585
+0%
|
70 911
+2%
|
|
| Equity | |||||||||||
| Common Stock |
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
6 593
|
|
| Retained Earnings |
36 392
|
37 810
|
39 655
|
42 096
|
43 822
|
44 833
|
46 354
|
48 861
|
53 463
|
59 254
|
|
| Additional Paid In Capital |
12 716
|
12 056
|
11 685
|
11 685
|
11 685
|
11 685
|
11 685
|
11 685
|
11 685
|
11 685
|
|
| Unrealized Security Profit/Loss |
1 474
|
0
|
232
|
753
|
22
|
457
|
137
|
193
|
314
|
2 002
|
|
| Treasury Stock |
4
|
0
|
5
|
5 601
|
10 566
|
13 847
|
14 998
|
17 593
|
18 265
|
18 266
|
|
| Other Equity |
5 398
|
6 401
|
5 192
|
10 006
|
7 673
|
3 703
|
6 213
|
5 542
|
12 288
|
18 354
|
|
| Total Equity |
62 571
N/A
|
63 735
+2%
|
63 352
-1%
|
65 532
+3%
|
59 186
-10%
|
52 510
-11%
|
55 985
+7%
|
54 895
-2%
|
65 450
+19%
|
79 623
+22%
|
|
| Total Liabilities & Equity |
96 268
N/A
|
119 178
+24%
|
114 358
-4%
|
115 401
+1%
|
110 434
-4%
|
104 156
-6%
|
121 860
+17%
|
124 282
+2%
|
135 035
+9%
|
150 534
+11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
53
|
53
|
53
|
50
|
48
|
46
|
46
|
44
|
44
|
44
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
